Back to top
more

Innospec (IOSP)

(Delayed Data from NSDQ)

$79.35 USD

79.35
162,606

+0.80 (1.02%)

Updated Aug 4, 2025 03:59 PM ET

After-Market: $79.27 -0.08 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Northern Technologies (NTIC) Q3 Earnings Lag Estimates

by Zacks Equity Research

Northern Technologies (NTIC) delivered earnings and revenue surprises of -50.00% and +3.91%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Northern Technologies (NTIC) Q3 Earnings Lag Estimates

by Zacks Equity Research

Northern Technologies (NTIC) delivered earnings and revenue surprises of -50.00% and +3.91%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Innospec's Earnings Surpass Estimates in Q1, Revenues Miss

by Zacks Equity Research

IOSP sees strong results in the Fuel Specialties unit in Q1 with higher margins driving a double-digit year-over-year increase in operating income.

Zacks Equity Research

Innospec (IOSP) Q1 Earnings Top Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of 1.43% and 4.03%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Compass Minerals (CMP) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Compass (CMP) delivered earnings and revenue surprises of 61.54% and 19.50%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Wall Street Analysts Predict a 39.97% Upside in Innospec (IOSP): Here's What You Should Know

by Zacks Equity Research

The consensus price target hints at a 40% upside potential for Innospec (IOSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Eastman Chemical (EMN) Q1 Earnings Beat Estimates

by Zacks Equity Research

Eastman Chemical (EMN) delivered earnings and revenue surprises of 1.06% and 0.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Methanex (MEOH) Soars 17.1%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Methanex (MEOH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Innospec Announces New $50 Million Share Repurchase Program

by Zacks Equity Research

IOSP's earlier $50 million share repurchase program expires in the first quarter of 2025.

Zacks Equity Research

Innospec (IOSP) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of 3.68% and 3.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Avient (AVNT) Q4 Earnings Top Estimates

by Zacks Equity Research

Avient (AVNT) delivered earnings and revenue surprises of 2.08% and 0.63%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Air Products and Chemicals (APD) Q1 Earnings Match Estimates

by Zacks Equity Research

Air Products and Chemicals (APD) delivered earnings and revenue surprises of 0% and 2.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cabot (CBT) Q1 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Cabot (CBT) delivered earnings and revenue surprises of -2.22% and 3.83%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Innospec (IOSP) Q3 Earnings Meet Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Albemarle (ALB) Q3 Earnings Expected to Decline

by Zacks Equity Research

Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Earnings Preview: Innospec (IOSP) Q3 Earnings Expected to Decline

by Zacks Equity Research

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Tronox (TROX) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tronox (TROX) delivered earnings and revenue surprises of -176.47% and 1.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Innospec's (IOSP) Q2 Earnings Surpass Estimates, Sales Miss

by Zacks Equity Research

Innospec (IOSP) sees strong results in its Performance Chemicals and Fuel Specialties segments in the second quarter on higher volumes.

Zacks Equity Research

Innospec (IOSP) Q2 Earnings Top Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of 1.46% and 9.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Air Products and Chemicals (APD) Q3 Earnings Beat Estimates

by Zacks Equity Research

Air Products and Chemicals (APD) delivered earnings and revenue surprises of 5.26% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Albemarle (ALB) Misses Q2 Earnings Estimates

by Zacks Equity Research

Albemarle (ALB) delivered earnings and revenue surprises of -92.45% and 2.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

PPG Industries (PPG) Q2 Earnings Top Estimates, Sales Lag

by Zacks Equity Research

PPG Industries (PPG) second-quarter revenues are adversely impacted by unfavorable foreign currency translation.